{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T11:09:23Z","timestamp":1768907363994,"version":"3.49.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Harm Reduct J"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12954-016-0095-0","type":"journal-article","created":{"date-parts":[[2016,2,16]],"date-time":"2016-02-16T02:43:50Z","timestamp":1455590630000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Opioid tolerance in methadone maintenance treatment: comparison of methadone and levomethadone in long-term treatment"],"prefix":"10.1186","volume":"13","author":[{"given":"Stefan","family":"Gutwinski","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikola","family":"Schoofs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heiner","family":"Stuke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas G.","family":"Riemer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Corinde E.","family":"Wiers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felix","family":"Bermpohl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,2,16]]},"reference":[{"issue":"9148","key":"95_CR1","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0140-6736(98)05356-2","volume":"353","author":"J Ward","year":"1999","unstructured":"Ward J, Hall W, Mattick RP. Role of maintenance treatment in opioid dependence. Lancet. 1999;353(9148):221\u20136. doi: 10.1016\/S0140-6736(98)05356-2 .","journal-title":"Lancet"},{"key":"95_CR2","doi-asserted-by":"crossref","unstructured":"Holland R, Maskrey V, Swift L, Notley C, Robinson A, Nagar J et al. Treatment retention, drug use and social functioning outcomes in those receiving 3 months versus 1 month of supervised opioid maintenance treatment. Results from the Super C randomized controlled trial. Addiction. 2013. doi: 10.1111\/add.12439 .","DOI":"10.1111\/add.12439"},{"key":"95_CR3","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s12954-015-0047-0","volume":"12","author":"PW Wang","year":"2015","unstructured":"Wang PW, Lin HC, Yen CN, Yeh YC, Hsu CY, Chung KS, et al. Comparison of outcomes after 3-month methadone maintenance treatment between heroin users with and without HIV infection: a 3-month follow-up study. Harm Reduction J. 2015;12:13. doi: 10.1186\/s12954-015-0047-0 .","journal-title":"Harm Reduction J"},{"key":"95_CR4","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1477-7517-11-15","volume":"11","author":"K Wang","year":"2014","unstructured":"Wang K, Fu H, Longfield K, Modi S, Mundy G, Firestone R. Do community-based strategies reduce HIV risk among people who inject drugs in China? A quasi-experimental study in Yunnan and Guangxi provinces. Harm Reduction J. 2014;11:15. doi: 10.1186\/1477-7517-11-15 .","journal-title":"Harm Reduction J"},{"issue":"3","key":"95_CR5","doi-asserted-by":"crossref","first-page":"214","DOI":"10.2307\/2137033","volume":"29","author":"JC Ball","year":"1988","unstructured":"Ball JC, Lange WR, Myers CP, Friedman SR. Reducing the risk of AIDS through methadone maintenance treatment. J Health Soc Behav. 1988;29(3):214\u201326.","journal-title":"J Health Soc Behav"},{"issue":"3","key":"95_CR6","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1111\/j.1360-0443.1992.tb01945.x","volume":"87","author":"J Ward","year":"1992","unstructured":"Ward J, Darke S, Hall W, Mattick R. Methadone maintenance and the human immunodeficiency virus: current issues in treatment and research. Br J Addict. 1992;87(3):447\u201353.","journal-title":"Br J Addict"},{"issue":"2","key":"95_CR7","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3109\/10826089609045806","volume":"31","author":"JR Caplehorn","year":"1996","unstructured":"Caplehorn JR, Dalton MS, Haldar F, Petrenas AM, Nisbet JG. Methadone maintenance and addicts\u2019 risk of fatal heroin overdose. Subst Use Misuse. 1996;31(2):177\u201396. doi: 10.3109\/10826089609045806 .","journal-title":"Subst Use Misuse"},{"issue":"6955","key":"95_CR8","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1136\/bmj.309.6955.641","volume":"309","author":"P Wilson","year":"1994","unstructured":"Wilson P, Watson R, Ralston GE. Methadone maintenance in general practice: patients, workload, and outcomes. BMJ. 1994;309(6955):641\u20134.","journal-title":"BMJ"},{"key":"95_CR9","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s12954-015-0072-z","volume":"12","author":"TH Kwan","year":"2015","unstructured":"Kwan TH, Wong NS, Lee SS. Participation dynamics of a cohort of drug users in a low-threshold methadone treatment programme. Harm Reduction J. 2015;12:30. doi: 10.1186\/s12954-015-0072-z .","journal-title":"Harm Reduction J"},{"key":"95_CR10","doi-asserted-by":"crossref","unstructured":"Coid J, Carvell A, Kittler Z, Healey A, Henderson J. Opiates, criminal behaviour, and methadone treatment. 2000.","DOI":"10.1037\/e665482007-001"},{"key":"95_CR11","volume-title":"NTORS after five years: the National Treatment Outcome Research Study; changes in substance use, health and criminal behaviour during the five years after intake","author":"M Gossop","year":"2001","unstructured":"Gossop M, Mardsen J, Stewart D. NTORS after five years: the National Treatment Outcome Research Study; changes in substance use, health and criminal behaviour during the five years after intake. London: National Addiction Centre; 2001."},{"key":"95_CR12","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1477-7517-11-6","volume":"11","author":"P Havinga","year":"2014","unstructured":"Havinga P, van der Velden C, de Gee A, van der Poel A. Differences in sociodemographic, drug use and health characteristics between never, former and current injecting, problematic hard-drug users in the Netherlands. Harm Reduction J. 2014;11:6. doi: 10.1186\/1477-7517-11-6 .","journal-title":"Harm Reduction J"},{"key":"95_CR13","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1001\/jama.1965.03090080008002","volume":"193","author":"VP Dole","year":"1965","unstructured":"Dole VP, Nyswander M. A medical treatment for diacetylmorphine (heroin) addiction: a clinical trial with methadone hydrochloride. JAMA. 1965;193:646\u201350.","journal-title":"JAMA"},{"key":"95_CR14","first-page":"122","volume":"79","author":"VP Dole","year":"1966","unstructured":"Dole VP, Nyswander ME, Kreek MJ. Narcotic blockade\u2014a medical technique for stopping heroin use by addicts. Trans Assoc Am Phys. 1966;79:122\u201336.","journal-title":"Trans Assoc Am Phys"},{"key":"95_CR15","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1749-6632.1978.tb16775.x","volume":"311","author":"VP Dole","year":"1978","unstructured":"Dole VP, Joseph H. Long-term outcome of patients treated with methadone maintenance. Ann N Y Acad Sci. 1978;311:181\u20139.","journal-title":"Ann N Y Acad Sci"},{"issue":"9","key":"95_CR16","first-page":"1409","volume":"77","author":"VP Dole","year":"1977","unstructured":"Dole VP, Joseph H. Methadone maintenance: outcome after termination. N Y State J Med. 1977;77(9):1409\u201312.","journal-title":"N Y State J Med"},{"issue":"7\u20138","key":"95_CR17","first-page":"435","volume":"71","author":"CE Inturrisi","year":"2005","unstructured":"Inturrisi CE. Pharmacology of methadone and its isomers. Minerva Anestesiol. 2005;71(7\u20138):435\u20137.","journal-title":"Minerva Anestesiol"},{"issue":"1","key":"95_CR18","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s11916-009-0006-0","volume":"13","author":"JA Trafton","year":"2009","unstructured":"Trafton JA, Ramani A. Methadone: a new old drug with promises and pitfalls. Curr Pain Headache Rep. 2009;13(1):24\u201330.","journal-title":"Curr Pain Headache Rep"},{"issue":"8","key":"95_CR19","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1002\/hup.630","volume":"19","author":"JM Corkery","year":"2004","unstructured":"Corkery JM, Schifano F, Ghodse AH, Oyefeso A. The effects of methadone and its role in fatalities. Hum Psychopharmacol. 2004;19(8):565\u201376. doi: 10.1002\/hup.630 .","journal-title":"Hum Psychopharmacol"},{"issue":"1","key":"95_CR20","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1055\/s-2003-36558","volume":"38","author":"E Freye","year":"2003","unstructured":"Freye E, Latasch L. Development of opioid tolerance\u2014molecular mechanisms and clinical consequences. AINSAnasthesiol Intensivmed Notfallmed Schmerzther. 2003;38(1):14\u201326. doi: 10.1055\/s-2003-36558 .","journal-title":"AINSAnasthesiol Intensivmed Notfallmed Schmerzther"},{"issue":"2","key":"95_CR21","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.pharmthera.2007.10.003","volume":"117","author":"T Koch","year":"2008","unstructured":"Koch T, Hollt V. Role of receptor internalization in opioid tolerance and dependence. Pharmacol Ther. 2008;117(2):199\u2013206. doi: 10.1016\/j.pharmthera.2007.10.003 .","journal-title":"Pharmacol Ther"},{"issue":"1","key":"95_CR22","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1124\/pr.112.005942","volume":"65","author":"JT Williams","year":"2013","unstructured":"Williams JT, Ingram SL, Henderson G, Chavkin C, von Zastrow M, Schulz S, et al. Regulation of mu-opioid receptors: desensitization, phosphorylation, internalization, and tolerance. Pharmacol Rev. 2013;65(1):223\u201354. doi: 10.1124\/pr.112.005942 .","journal-title":"Pharmacol Rev"},{"issue":"4","key":"95_CR23","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1124\/mol.108.048512","volume":"74","author":"S Arttamangkul","year":"2008","unstructured":"Arttamangkul S, Quillinan N, Low MJ, von Zastrow M, Pintar J, Williams JT. Differential activation and trafficking of micro-opioid receptors in brain slices. Mol Pharmacol. 2008;74(4):972\u20139. doi: 10.1124\/mol.108.048512 .","journal-title":"Mol Pharmacol"},{"issue":"3","key":"95_CR24","doi-asserted-by":"crossref","first-page":"679","DOI":"10.36076\/ppj.2009\/12\/679","volume":"12","author":"SM Silverman","year":"2009","unstructured":"Silverman SM. Opioid induced hyperalgesia: clinical implications for the pain practitioner. Pain Physician. 2009;12(3):679\u201384.","journal-title":"Pain Physician"},{"issue":"4","key":"95_CR25","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1111\/j.1476-5381.2011.01335.x","volume":"164","author":"MM Morgan","year":"2011","unstructured":"Morgan MM, Christie MJ. Analysis of opioid efficacy, tolerance, addiction and dependence from cell culture to human. Br J Pharmacol. 2011;164(4):1322\u201334. doi: 10.1111\/j.1476-5381.2011.01335.x .","journal-title":"Br J Pharmacol"},{"issue":"2","key":"95_CR26","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/S0022-3565(24)38234-5","volume":"289","author":"AM Davis","year":"1999","unstructured":"Davis AM, Inturrisi CE. d-Methadone blocks morphine tolerance and N-methyl-D-aspartate-induced hyperalgesia. J Pharmacol Exp Ther. 1999;289(2):1048\u201353.","journal-title":"J Pharmacol Exp Ther"},{"issue":"3","key":"95_CR27","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1097\/00000542-200703000-00022","volume":"106","author":"JR Holtman Jr","year":"2007","unstructured":"Holtman Jr JR, Wala EP. Characterization of the antinociceptive and pronociceptive effects of methadone in rats. Anesthesiology. 2007;106(3):563\u201371.","journal-title":"Anesthesiology"},{"key":"95_CR28","author":"LK Bald","year":"2013","unstructured":"Bald LK, Bermpohl F, Heinz A, Gallinat J, Gutwinski S. Heroin or conventional opioid maintenance? The patients\u2019 perspective. J Addict Med. 2013. doi: 10.1097\/ADM.0b013e3182a11ad0 .","journal-title":"J Addict Med"},{"issue":"23\u201324","key":"95_CR29","first-page":"405","volume":"110","author":"S Gutwinski","year":"2013","unstructured":"Gutwinski S, Bald LK, Heinz A, Muller CA, Schmidt AK, Wiers C, et al. Take home maintenance medication in opiate dependence. Deutsches Arzteblatt Int. 2013;110(23\u201324):405\u201312. doi: 10.3238\/arztebl.2013.0405 .","journal-title":"Deutsches Arzteblatt Int"},{"key":"95_CR30","author":"S Gutwinski","year":"2013","unstructured":"Gutwinski S, Bald LK, Gallinat J, Heinz A, Bermpohl F. Why do patients stay in opioid maintenance treatment? Subst Use Misuse. 2013. doi: 10.3109\/10826084.2013.863344 .","journal-title":"Subst Use Misuse"},{"key":"95_CR31","doi-asserted-by":"crossref","unstructured":"Schoofs N, Riemer T, Bald LK, Heinz A, Gallinat J, Bermpohl F et al. Methadone and levomethadone\u2014dosage and side effects.. Psychiatrische Praxis. 2013. doi: 10.1055\/s-0033-1349627 .","DOI":"10.1055\/s-0033-1349627"},{"issue":"7577","key":"95_CR32","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1136\/bmj.39016.471840.68","volume":"333","author":"A Bakker","year":"2006","unstructured":"Bakker A, Fazey C. Methadone tolerance testing in drug misusers. BMJ. 2006;333(7577):1056\u20139. doi: 10.1136\/bmj.39016.471840.68 .","journal-title":"BMJ"},{"key":"95_CR33","first-page":"CD002208","volume":"3","author":"F Faggiano","year":"2003","unstructured":"Faggiano F, Vigna-Taglianti F, Versino E, Lemma P. Methadone maintenance at different dosages for opioid dependence. Cochrane database Syst Rev. 2003;3:CD002208. doi: 10.1002\/14651858.CD002208 .","journal-title":"Cochrane database Syst Rev"},{"issue":"5","key":"95_CR34","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1007\/s00414-014-1017-x","volume":"128","author":"S Iwersen-Bergmann","year":"2014","unstructured":"Iwersen-Bergmann S, Jungen H, Andresen-Streichert H, Muller A, Elakkary S, Puschel K, et al. Intravenous methadone application as a serious risk factor for an overdose death: methadone-related fatalities in Hamburg from 2007 to 2012. Int J Legal Med. 2014;128(5):751\u201364. doi: 10.1007\/s00414-014-1017-x .","journal-title":"Int J Legal Med"},{"key":"95_CR35","doi-asserted-by":"crossref","first-page":"c3172","DOI":"10.1136\/bmj.c3172","volume":"341","author":"J Kimber","year":"2010","unstructured":"Kimber J, Copeland L, Hickman M, Macleod J, McKenzie J, De Angelis D, et al. Survival and cessation in injecting drug users: prospective observational study of outcomes and effect of opiate substitution treatment. BMJ. 2010;341:c3172. doi: 10.1136\/bmj.c3172 .","journal-title":"BMJ"},{"issue":"4","key":"95_CR36","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.jsat.2005.02.007","volume":"28","author":"L Amato","year":"2005","unstructured":"Amato L, Davoli M, Perucci CA, Ferri M, Faggiano F, Mattick RP. An overview of systematic reviews of the effectiveness of opiate maintenance therapies: available evidence to inform clinical practice and research. J Subst Abus Treat. 2005;28(4):321\u20139. doi: 10.1016\/j.jsat.2005.02.007 .","journal-title":"J Subst Abus Treat"},{"issue":"7","key":"95_CR37","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1097\/00005053-198807000-00003","volume":"176","author":"JB Milby","year":"1988","unstructured":"Milby JB. Methadone maintenance to abstinence. How many make it? J Nerv Ment Dis. 1988;176(7):409\u201322.","journal-title":"J Nerv Ment Dis"},{"issue":"1","key":"95_CR38","first-page":"62","volume":"68","author":"S Magura","year":"2001","unstructured":"Magura S, Rosenblum A. Leaving methadone treatment: lessons learned, lessons forgotten, lessons ignored. Mt Sinai J Med. 2001;68(1):62\u201374.","journal-title":"Mt Sinai J Med"}],"container-title":["Harm Reduction Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-016-0095-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T11:43:00Z","timestamp":1748778180000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.harmreductionjournal.com\/content\/13\/1\/7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2,16]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["95"],"URL":"https:\/\/doi.org\/10.1186\/s12954-016-0095-0","relation":{},"ISSN":["1477-7517"],"issn-type":[{"value":"1477-7517","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,16]]},"article-number":"7"}}